Despite being early-stage tumors, thin cutaneous melanomas contribute significantly to mortality and have a rising incidence. A retrospective case–control study was performed to identify clinical–dermoscopic and histopathological variables linked to local and distant metastases in melanomas ≤0.8 mm. Data from 1 January 2000 to 22 June 2022 were analyzed from two Italian skin cancer referral centers. Sixteen patients with ≤0.8 mm melanomas developing metastases were studied compared to controls without metastases over 5 years. Statistical analysis involved Pearson’s chi-squared test or Fisher’s exact test. Of the 1396 cases, 1.1% progressed. The median diagnosis age was 49 (range 28–83), with 56.3% men and 43.7% women. The torso was the primary tumor site (43.7%). Clinically, lesions were pigmented (>10 mm diameter: 73.3%, ≥3 colors: 80%). Dermoscopically, the common features were white patches (73.3%), atypical vascular patterns (66.5%), blue-gray areas (60%) and absent pigment networks (60%). Histopathologically, all cases had adverse features like regression (87.4%), dermal mitoses (50%), a vertical growth phase (62.5%) and ulceration (12.5%). These findings were statistically significant compared to controls (p < 0.05). In ≤0.8 mm melanomas, specific clinical–dermoscopic traits might indicate higher metastatic potential when paired with adverse histopathological features.
Background: The relationship between occupational sun exposure and melanoma risk is complex and multifaceted, with existing evidence yielding contradictory findings. Unlike Non-Melanoma Skin Cancer (NMSC), for which occupational sun exposure is a well-established risk factor, the link with cutaneous melanoma remains contentious. Objectives: This study aimed to evaluate whether, in a cohort of patients with cutaneous melanoma, an association existed between occupational sun exposure and melanoma, specifically with histotype, site of occurrence, and Breslow index. Methods: This is a retrospective cohort analysis conducted to evaluate whether occupational sun exposure constitutes a risk factor for the development of cutaneous melanoma in patients diagnosed between January 2005 and October 2023 at the Dermatology Unit, Azienda USL Toscana Centro, Florence. Occupational ultraviolet (UV) exposure was examined by classifying each participant’s job into categories based on solar UV exposure levels—outdoor (e.g., agriculture and construction roles), mixed indoor/outdoor (e.g., trades and public safety professions), and indoor settings (e.g., office-based work). Results: A final total of 1417 patients were analyzed. Occupational categorization revealed that 1171 patients (82.64%) were classified as non-occupationally exposed (indoor), while 246 (17.36%) were occupationally exposed to solar UV radiation (including 14.82% mixed indoor/outdoor and 2.54% outdoor workers). A significant association was observed between occupational sun exposure and lentigo maligna, which was more prevalent among exposed workers and even more so in the outdoor subgroup. Anatomical site distribution exhibited a significant association with occupational sun exposure. Indeed occupationally exposed individuals showed a higher prevalence of melanomas in the head and neck region, a distribution pattern particularly evident among outdoor workers, suggesting that these sites may be more susceptible to chronic sun exposure in outdoor and mixed occupations. Moreover, a significant association was found between occupational exposure and Breslow thickness, with exposed workers presenting with thicker melanomas at diagnosis, suggesting more advanced disease. Conclusions: The finding of this study may reflect variations in occupational sun exposure patterns and warrants further investigation into protective measures and early-detection strategies tailored to occupational groups.
Background: Dermoscopy has increased the excision of very small pigmented lesions in routine practice, yet the diagnostic efficiency of excising lesions ≤ 6 mm judged suspicious for melanoma remains incompletely defined. Objectives: The objectives of this study were to quantify melanoma detection yield and number needed to excise (NNE) for pigmented lesions ≤ 6 mm excised after clinical and dermoscopic suspicion of melanoma and to describe melanoma characteristics according to lesion diameter. Methods: We performed a retrospective observational cross-sectional study at a tertiary dermatologic oncology referral center within the Tuscany Regional Health Service, Florence, Italy. All pigmented lesions excised between 1 January 2022 and 31 December 2023 were screened. Consecutive lesions were included if they were excised because melanoma or suspected melanoma was the preoperative clinicodermoscopic diagnosis; lesions removed for benign or cosmetic indications were excluded. Primary outcomes were melanoma yield and number needed to excise, overall and stratified by clinical diameter. Multivariable logistic regression was performed to assess whether lesion diameter was independently associated with melanoma diagnosis after adjustment for age, sex, and anatomical site. Results: Among 2240 included excisions, 609 melanomas were diagnosed, corresponding to an overall yield of 27.2%. Lesions ≤ 6 mm accounted for 1331 excisions and yielded 175 melanomas, with a yield of 13.1% and a number needed to excise of 7.6. Lesions > 6 mm accounted for 909 excisions and yielded 434 melanomas, with a yield of 47.7% and a number needed to excise of 2.1. Thus, 86.9% of excised lesions ≤ 6 mm were benign on histopathology. Melanomas diagnosed in lesions ≤ 6 mm showed a more favorable histopathologic profile than larger melanomas. In multivariable analysis, lesions > 6 mm had significantly higher odds of melanoma than lesions ≤ 6 mm after adjustment for age, sex, and anatomical site (adjusted odds ratio 4.77, 95% confidence interval 3.81–5.97; p < 0.001). Conclusions: In routine practice, excision of dermoscopically suspicious pigmented lesions ≤ 6 mm has markedly lower melanoma yield and higher NNE than excision of larger lesions. These findings support risk-stratified management approaches and careful consideration of excision thresholds for very small lesions.
30 September 2026 in International Journal of Dermatology
Cutaneous and mucosal angiosarcoma (CMA) is a rare and aggressive tumor of vascular endothelial cells that can occur in any body site, including the skin and mucosa. A history of radiation and chronic lymphedema are well-established risk factors, but the causes of sporadic CMA are less clear. Dermoscopy has emerged as a useful noninvasive tool that can aid in diagnosing cutaneous tumors, including CMA, by providing magnified images of the skin surface and subsurface structures. However, to date, little is known about the dermoscopic patterns of CMA. This study aimed to evaluate the clinical and dermatoscopic features of CMA in order to create a classification that can be useful in the early diagnosis of this rare but fearful tumor. A descriptive, retrospective analysis was conducted on the clinical and dermoscopic characteristics of histopathologically confirmed cases of CMA. The study population consisted of 10 patients with a histologically confirmed diagnosis of CMA, including 6 males (60%) and 4 females (40%). By analyzing our cases clinically and dermoscopically, we classify them into three configurations to facilitate an early and more accurate diagnosis: melanoma-like pattern, benign vascular-like pattern (both cutaneous and mucosal), and inflammatory-like pattern. The identification of CMA poses a diagnostic dilemma for clinicians, as its clinical presentation often overlaps with other benign and malignant dermatological conditions. Dermoscopy, although it does not provide specific or pathognomonic parameters, may improve the diagnostic accuracy of these lesions in conjunction with clinical and histological features. For the first time in the literature, we have attempted to classify the extreme clinical and dermoscopic polymorphism of angiosarcoma by describing three patterns that can be extremely useful for achieving an early and accurate diagnosis of this fearsome and aggressive tumor.